These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1854886)

  • 21. Cyclosporin in the treatment of severe aplastic anemia: report of one case.
    Cheng J; Lin KH; Hwang KC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(4):261-5. PubMed ID: 2637607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic hypereosinophilic syndrome with eosinophilic myositis, peripheral neuropathy and central nervous system involvement.
    Lee JD; Chen ST; Chen CJ; Chen CM; Ro LS
    J Formos Med Assoc; 1996 Dec; 95(12):933-6. PubMed ID: 9000811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged clinical response to vincristine treatment in two patients with idiopathic hypereosinophilic syndrome.
    Sakamoto K; Erdreich-Epstein A; deClerck Y; Coates T
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):348-51. PubMed ID: 1456402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare case of hypereosinophilic syndrome presenting with unilateral proptosis and torticollis.
    Das JK; Gupta K; Deshmukh S; Shrivastava R
    Indian J Ophthalmol; 2018 Oct; 66(10):1508-1511. PubMed ID: 30249857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypereosinophilic syndrome: progression of peripheral neuropathy despite controlled eosinophil levels.
    Cengiz B; Sucak G; Kuruoğlu R; Tan E
    Acta Neurol Belg; 1999 Jun; 99(2):133-7. PubMed ID: 10427356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.
    Fauci AS; Harley JB; Roberts WC; Ferrans VJ; Gralnick HR; Bjornson BH
    Ann Intern Med; 1982 Jul; 97(1):78-92. PubMed ID: 7046556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypereosinophilic syndrome with DIC treated successfully with a combination of high-dose methylprednisolone and cyclosporin A].
    Fukuta A; Hara T; Tsurumi H; Moriwaki H
    Rinsho Ketsueki; 2001 Nov; 42(11):1145-7. PubMed ID: 11808087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of dermatologic disease with cyclosporin A.
    Brown MD; Gupta AK; Ellis CN; Rocher LL; Voorhees JJ
    Adv Dermatol; 1989; 4():3-27; discussion 28. PubMed ID: 2701795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Very Rare Case of Hypereosinophilic Syndrome Secondary to Natural Killer/T-Cell Lymphoma.
    Yamamoto T; Kamijo A; Nakazawa T; Nakajima K; Kirito K; Komatsu N; Masuyama K
    Case Rep Otolaryngol; 2018; 2018():5965029. PubMed ID: 29785315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical analysis of 90 cases of eosinophilia and pulmonary infiltrates with peripheral eosinophilia].
    Li LY; Xue CS; Luo WC
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):659-62, 702. PubMed ID: 2086006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
    Isvy-Joubert A; Hickman G; Flageul B; Battistella M; Bagot M; Galicier L; Petit A
    Ann Dermatol Venereol; 2012 Oct; 139(10):636-40. PubMed ID: 23122377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interleukin 2 receptor in the hypereosinophilic syndrome.
    Plumas J; Gruart V; Capron M; Capron A; Prin L
    Leuk Lymphoma; 1992 Dec; 8(6):449-57. PubMed ID: 1297479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.
    Bobbio-Pallavicini E; Confalonieri M; Tacconi F; Mainardi E; Della Porta R; Ceccato D; Maccario R; De Amici M
    Panminerva Med; 1998 Sep; 40(3):186-90. PubMed ID: 9785914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia.
    Takai K; Sanada M
    Int J Hematol; 1991 Jun; 54(3):231-9. PubMed ID: 1747458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hepatitis in hypereosinophilic syndrome: report of an unusual case.
    Minola E; Sonzogni A
    Infez Med; 2005 Sep; 13(3):182-6. PubMed ID: 16397421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interferon-alpha therapy in the myeloproliferative variants of hypereosinophilic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Rinsho Ketsueki; 1993 Mar; 34(3):367-72. PubMed ID: 8479090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypereosinophilic syndromes.
    Butterfield JH
    BioDrugs; 1997 May; 7(5):341-55. PubMed ID: 18031098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
    La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C
    Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple venous aneurysms in a patient with hypereosinophilic syndrome.
    Malskat WS; Racz E; ten Raa S; Lugtenburg PJ; Hegt VN; de Maeseneer MG
    Phlebology; 2016 Feb; 31(1):66-8. PubMed ID: 25505272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.